首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 歐洲心臟血管治療藥市場
產業/市場分類
製藥 (4495)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (168)
神經疾病 (175)
骨頭疾病治療 (41)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (318)
精神病 (80)
製藥企業 (506)
糖尿病 (157)
癌症 (838)
藥物開發 (1275)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

歐洲心臟血管治療藥市場

European Cardiovascular Drugs Markets

出版商 Frost & Sullivan
出版日期 2006年09月 商品編碼 45500
內容資訊 英文 149 Pages
價格
US $ 6500 Web Access (Regional License)
US $ 7000 Hard Copy & Web Access (Regional License)


歐洲心臟血管治療藥市場 是由出版商Frost & Sullivan在2006年09月所出版的。 這份英文市場調查報告書包含149 Pages 價格從美金6500起跳。

目錄

Abstract

This research examines the European Cardiovascular Market in terms of the challenges faced by market participants, drivers and restraints in the industry, the competitive structure in the major markets, the revenue forecasts and growth rates and strategic recommendations.

Table of Contents

1. EXECUTIVE SUMMARY

Overview

  • 1. Overview of the European Cardiovascular Drugs Market

2. GLOSSARY OF TERMS

List of Terms

  • 1. Abbreviations

3. INTRODUCTION

Disease State Overview

  • 1. Disease Description and Risk Factors
  • 2. Types of Heart Disease
  • 3. Disease Management and Current Treatments

Research Methodology

  • 1. Research Methodology for the European Cardiovascular Drugs Market
  • 2. Assumptions and Limitations

4. INDUSTRY CHALLENGES

Challenges and Issues

  • 1. Challenges Facing the European Cardiovascular Drugs Market

5. MARKET ENGINEERING RESEARCH FOR WORLD CARDIOVASCULAR DRUGS MARKET

World Cardiovascular Drugs Market

  • 1. Introduction
  • 2. Measurement Analysis
  • 3. Revenue Forecasts
  • 4. Trends by Geographic Regions
  • 5. Segment Analysis

6. MARKET ENGINEERING RESEARCH FOR EUROPEAN CARDIOVASCULAR DRUGS MARKET

European Cardiovascular Drugs Market

  • 1. Introduction and Market Segmentation
  • 2. Measurements Analysis
  • 3. Key Market Drivers
  • 4. Key Market Restraints
  • 5. Revenue Forecasts
  • 6. Segment-wise Analysis

7. CARDIOVASCULAR DRUGS MARKET IN THE UNITED KINGDOM

Research

  • 1. Market Overview
  • 2. Revenue Forecasts

8. CARDIOVASCULAR DRUGS MARKET IN GERMANY

Research

  • 1. Market Overview
  • 2. Revenue Forecasts

9. CARDIOVASCULAR DRUGS MARKET IN FRANCE

Research

  • 1. Market Overview
  • 2. Revenue Forecasts

10. CARDIOVASCULAR DRUGS MARKET IN ITALY

Research

  • 1. Market Overview
  • 2. Revenue Forecasts

11. CARDIOVASCULAR DRUGS MARKET IN SPAIN

Research

  • 1. Market Overview
  • 2. Revenue Forecasts

12. PORTFOLIO ANALYSIS

Company Profiles and Product Pipeline

  • 1. AstraZeneca
  • 2. Bristol-Myers Squibb
  • 3. Merck & Co. Inc
  • 4. Novartis
  • 5. Pfizer
  • 6. Sanofi-Aventis

13. STRATEGIC RECOMMENDATIONS

Recommendations

  • 1. Strategic Recommendations for the European Cardiovascular Drugs Market

14. DATABASE OF KEY INDUSTRY PARTICIPANTS

Key Industry Participants

  • 1. Major Participants

15. DECISION SUPPORT DATABASES

Cardiovascular Diseases

  • 1. Cardiovascular Prevalence
  • 2. Percent of Cardiovascular Disease Prevalence
  • 3. Prevalence of Hypertension
  • 4. Prevalence of Hypertension as Percentage of Population
  • 5. Incidence of Myocardial Infarction
  • 6. Incidence of Stroke
  • 7. Mortality due to Coronary Heart Disease
  • 8. Mortality due to Circulatory Disease
  • 9. Mortality due to Chronic Rheumatic Heart Disease
  • 10. Heart Attack Mortality
  • 11. Mortality due to Hypertensive Diseases
Back to Top